Thomas J Schnitzer

Grants

Grants per year 2002 2004 2005 2006 2007 2008 2009 2010 2012 2015 2016 2019 2020 2025

• 17 Active
• 85 Finished

Grants per year

Search results

• Active

  Prot#PARA_OA_006: An Observational Follow-up Study to Evaluate Duration of Treatment Effect of Pentosan Polysulfate Sodium in Participants with Knee Osteoarthritis Pain

  Schnitzer, T. J.

  Premier Research International, LLC, Paradigm Biopharmaceuticals (USA) Inc.

  12/27/22 → 12/27/25

  Project: Research project

• Prot#TGC-15302: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy and Safety of TG-C in Subjects with Kellgren and Lawrence Grade 2 or 3 Osteoarthritis of the Knee

  Schnitzer, T. J.

  Kolon TissueGene, Inc.

  3/17/22 → 3/17/25

  Project: Research project

• Prot #PARA_OA_002: A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared with Placebo in Participants with Knee Osteoarthritis Pain

  Schnitzer, T. J.

  Premier Research International, LLC, Paradigm Biopharmaceuticals (USA) Inc.

  1/18/22 → 1/18/25

  Project: Research project

• Prot #TF-X0002-31: A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects with Osteoarthritis of t

  Schnitzer, T. J.

  Premier Research International, LLC, Techfields, Inc.

  10/15/21 → 10/15/24

  Project: Research project

• Prot #CDFV890B12201: A Randomized, Two-arm, Placebo-controlled, Participant and Investigator-Blinded Study Investigating the Efficacy, Safety and Tolerability of DFV890 in Patients with Symptomatic Knee Osteoarthritis

  Schnitzer, T. J.

  Novartis Pharmaceuticals Corporation

  4/1/21 → 11/30/23

  Project: Research project

• Prot #20197268: Effects of Romosozumab on Bone Health in Women with Spinal Cord Injury and Osteoporosis

  Schnitzer, T. J.

  Amgen, Inc.

  12/21/20 → 12/21/23

  Project: Research project

• Prot #Cingal 19-01: A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee

  Schnitzer, T. J.

  SynteractHCR, Inc., Anika Therapeutics, Inc.

  9/11/20 → 9/11/23

  Project: Research project

• Data Center for Acute to Chronic Pain Biosignatures

  Apkarian, A., Griffith, J. W. & Schnitzer, T. J.

  Johns Hopkins University, National Institute on Drug Abuse

  8/1/20 → 7/31/23

  Project: Research project

  • data 100%
  • capacity 75%
  • pain 50%
  • Chronic Pain 50%
  • Neuroimaging 25%

• Prot #H0P-MC-CPMP: A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic Pain

  Schnitzer, T. J.

  Lilly USA, LLC

  7/29/20 → 7/29/23

  Project: Research project

• Prot #TLC599A3005: A Phase 3, Randomized, Double-blind, Placebo- and Active-controlled Study to Evaluate the Efficacy and Safety of TLC599 in Patients with Osteoarthritis of the Knee

  Schnitzer, T. J.

  Premier Research International, LLC, Taiwan Liposome Company, Ltd

  6/25/20 → 6/25/23

  Project: Research project

• Prot #R475-OA-1758: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients with Pain due to Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  inVentiv Health Clinical, Regeneron Pharmaceuticals, Inc.

  2/21/19 → 2/21/24

  Project: Research project

• Brain Pathophysiology of Osteoarthritis Pain

  Apkarian, A., Griffith, J. W., Kahnt, T., Manning, D. W., Parrish, T. B. & Schnitzer, T. J.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  2/1/19 → 12/31/23

  Project: Research project

  • pain 100%
  • Osteoarthritis 64%
  • Pain 64%
  • Brain 52%
  • Chronic Osteoarthritis 29%

• Prot #TGC-15302/KTG-15302: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy and Effectiveness of TG-C in Subjects with Kellgren and Lawrence Grade 2 or 3 Osteoarthritis of the Knee

  Schnitzer, T. J.

  Medpace Clinical Research LLC, Kolon TissueGene, Inc.

  1/28/19 → 1/28/24

  Project: Research project

• Center for chronic pain and drug abuse

  Apkarian, A., Cox, J. M., Drenan, R. M., Graves, S. M., Griffith, J. W., Huang, L., Jovasevic, V., Miller, R. J., Parrish, T. B., Procissi, D., Rodes, M. E., Schnitzer, T. J., Awatramani, R., Martina, M., Radulovic, J. & Surmeier Jr, D. J.

  National Institute on Drug Abuse

  9/1/18 → 6/30/23

  Project: Research project

  • pain 100%
  • Chronic Pain 86%
  • Opiate 73%
  • Brain 60%
  • brain 53%

• Prot# BA058-05-019: A Randomized, Double-blind, Placebo-controlled, Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of Abaloparatide-SC for the Treatment of Men with Osteoporosis

  Schnitzer, T. J.

  ICON Clinical Research, LLC, Radius Health, Inc.

  6/13/18 → 6/13/25

  Project: Research project

• D-Cycloserine for the Treatment of Chronic, Refractory Low Back Pain

  Schnitzer, T. J., Apkarian, A. & Griffith, J. W.

  U.S. Army Medical Research and Materiel Command

  9/30/17 → 9/29/23

  Project: Research project

  • pain 100%
  • Backache 32%
  • Cycloserine 28%
  • Pain 28%
  • brain 25%

• Prot #R475-PN-1523: A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients with Pain Due to Osteoarthritis of the Knee or Hip

  Schnitzer, T. J.

  ICON Clinical Research, LLC, Regeneron Pharmaceuticals, Inc.

  5/12/16 → 5/12/24

  Project: Research project

• Finished

  Transcranial Magnetic Stimulation to Enhance Cortical-Hippocampal Functional Connectivity as a Novel Means for Relieving Chronic OA Pain

  Apkarian, A., Schnitzer, T. J. & Voss, J. L.

  Pfizer Inc.

  5/24/21 → 5/23/22

  Project: Research project

• Prot #R475-OA-1816: Study to Evaluate Arthroplasty Specimens in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip

  Schnitzer, T. J.

  ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.

  5/14/19 → 5/14/22

  Project: Research project

• Prot #FX006-2018-015: A Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients with Hip Osteoarthritis

  Schnitzer, T. J.

  Flexion Therapeutics, Inc.

  2/6/19 → 2/6/22

  Project: Research project

• Prot #CL2-201086-002/GLPG1972-CL-201: Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with knee osteoarthritis. A 52-week international, multi-regional, multi-center, randomized, double-blind, placebo-controll

  Schnitzer, T. J.

  Medpace Clinical Research LLC, Galapagos NV

  12/4/18 → 12/4/21

  Project: Research project

• Prot #KF7013-03: Open-label safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS)

  Schnitzer, T. J.

  Worldwide Clinical Trials, Inc., Grunenthal GmbH

  1/17/17 → 1/17/22

  Project: Research project

• Increasing Bone Mass and Bone Strength in Individuals with Chronic Spinal Cord Injury: Maximizing Response to Therapy

  Schnitzer, T. J.

  U.S. Army Medical Research and Materiel Command

  9/30/16 → 3/29/19

  Project: Research project

  • bones 100%
  • Bone Mass 50%
  • Bone Strength 50%
  • therapy 25%
  • people 25%

• Prot #A4091056: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Analgesic Efficacy and Safety of a Dose Titration Regimen for the Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  INC Research, LLC, Pfizer Inc.

  8/2/16 → 8/2/19

  Project: Research project

• Cortico-striatal plasticity in the transition to chronic pain

  Apkarian, A., Griffith, J. W., Martina, M., Parrish, T. B., Procissi, D., Schnitzer, T. J. & Surmeier Jr, D. J.

  National Institute of Dental and Craniofacial Research

  7/1/16 → 12/31/18

  Project: Research project